- Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial2014 | 1. lékařská fakulta
- A multicenter, random.,double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treat.2006 | Fakulta tělesné výchovy a sportu
- The PREMIER Study. A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment2006 | 1. lékařská fakulta
- Současná evidence o léčbě revmatoidní artritidy biologickými, chorobu modifikujícími léky – systematicky literární přehled informující EULAR pro tvorbu Doporučení pro léčbu RA.2010 | 1. lékařská fakulta